v3.25.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Series A  preferred stock
Series A  preferred stock
Common stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Beginning balance (in shares) at Mar. 31, 2024   10,000 145,582,999      
Beginning balance at Mar. 31, 2024 $ 617,757 $ 0 $ 14 $ 1,441,518 $ 1,908 $ (825,683)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options exercised and restricted stock units vested and settled (in shares)     612,674      
Stock options exercised and restricted stock units vested and settled 686     686    
Capital contribution – stock-based compensation 12     12    
Stock-based compensation 13,443     13,443    
Foreign currency translation adjustments (88)       (88)  
Net loss (87,150)         (87,150)
Ending balance (in shares) at Jun. 30, 2024   10,000 146,195,673      
Ending balance at Jun. 30, 2024 544,660 $ 0 $ 14 1,455,659 1,820 (912,833)
Beginning balance (in shares) at Mar. 31, 2025   10,000 170,111,593      
Beginning balance at Mar. 31, 2025 707,447 $ 0 $ 16 1,945,495 1,459 (1,239,523)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock options exercised and restricted stock units vested and settled (in shares)     957,583      
Stock options exercised and restricted stock units vested and settled 2,918     2,918    
Capital contribution – stock-based compensation 115     115    
Stock-based compensation 18,395     18,395    
Foreign currency translation adjustments 278       278  
Net loss (120,613)         (120,613)
Ending balance (in shares) at Jun. 30, 2025   10,000 171,069,176      
Ending balance at Jun. 30, 2025 $ 608,540 $ 0 $ 16 $ 1,966,923 $ 1,737 $ (1,360,136)